Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women with Dysmenorrhea Receiving Different Treatments: Prospective Observational Study

Osamu Yoshino, Noriko Takahashi, Yoshimi Suzukamo, Osamu Yoshino, Noriko Takahashi, Yoshimi Suzukamo

Abstract

Introduction: Dysmenorrhea is a physical and mental burden for women, negatively affecting health-related quality of life (HRQL) and work productivity. However, data on HRQL and work productivity of Japanese women are scarce.

Methods: In this prospective observational study, 397 Japanese women received low-dose estrogen/progestin (LEP) or non-LEP treatment (non-steroidal anti-inflammatory drugs or Chinese herbal medicines) for primary/secondary dysmenorrhea and completed survey questionnaires online regarding menstrual symptoms, HRQL, and work productivity. Regression analysis was performed to compare the groups and evaluate outcomes over time using the paired t test. Subgroup analysis was performed using stratification by patient background, and correlations between improvement in menstrual symptoms/HRQL and work productivity were investigated using Spearman's rank correlation coefficient.

Results: Significant reductions in the modified Menstrual Distress Questionnaire (mMDQ) total score were shown in the LEP group (n = 251) (P < 0.01), but not the non-LEP group (n = 146). Significant improvements in HRQL, measured by the 36-Item Short-Form Health Survey v2.0 (SF-36v2.0), were shown in the LEP group, but not the non-LEP group. Improvements were seen in mental component summary and 7/8 domains (role physical, bodily pain, general health, role emotional, mental health, vitality, and social functioning) in the LEP group, but not the non-LEP group. There were no differences in the physical component summary and role functioning in either group. Improvements in work productivity, measured by the modified Work Productivity and Activity Impairment Questionnaire (mWPAI), were greater in the LEP group vs. non-LEP group. Regression analysis showed differences in improvements between the groups in the mMDQ total score, SF-36v2.0, and mWPAI. A correlation between mMDQ or HRQL and work productivity was seen.

Conclusion: In Japanese women, dysmenorrhea is associated with reduced HRQL and work productivity. In real-world clinical practice, improvements in physical and mental menstrual symptoms, HRQL, and work productivity were observed with LEP treatment.

Trial registration: NCT04607382 (ClinicalTrials.gov).

Keywords: Dysmenorrhea; Health-Related Quality of Life; LEP; Menstrual Symptoms; PRO/QOL: Trial Based; Women’s Health; Work Productivity.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Changes in mMDQ total score in the LEP and non-LEP groups before and during menstruation. LEP low-dose estrogen/progestin (cyclic or extended), mMDQ modified Menstrual Distress Questionnaire, NS not significant. **P < 0.01 (vs. day 1)
Fig. 2
Fig. 2
Change in SF-36v2.0 total score in the LEP and the non-LEP groups during menstrual periods. The dotted line indicates the standardized mean Japanese norm score. BP bodily pain, GH general health, LEP low-dose estrogen/progestin (cyclic or extended), MCS mental component score, MH mental health, NS not significant, PCS physical component score, PF physical functioning, RE role emotional, RP role physical, SF social functioning, SF-36v2.0 36-Item Short-Form Health Survey version 2.0, VT vitality. **P < 0.01 (vs. day 1)
Fig. 3
Fig. 3
Change in mWPAI in the LEP and the non-LEP groups during menstrual periods. LEP low-dose estrogen/progestin (cyclic or extended), NS not significant, mWPAI modified Work Productivity and Activity Impairment Questionnaire. *P < 0.05 (vs. day 1), **P < 0.01 (vs. day 1)

References

    1. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104–113. doi: 10.1093/epirev/mxt009.
    1. Chen CX, Draucker CB, Carpenter JS. What women say about their dysmenorrhea: a qualitative thematic analysis. BMC Womens Health. 2018;18:47. doi: 10.1186/s12905-018-0538-8.
    1. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134–1138. doi: 10.1136/bmj.332.7550.1134.
    1. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21:762–768. doi: 10.1093/humupd/dmv039.
    1. Nagy H, Khan MAB. Dysmenorrhea. StatPearls. . 2021. Accessed Aug 31, 2021.
    1. Tanaka E, Momoeda M, Osuga Y, et al. Burden of menstrual symptoms in Japanese women: results from a survey-based study. J Med Econ. 2013;16:1255–1266. doi: 10.3111/13696998.2013.830974.
    1. Osuga Y, Hayashi K, Kobayashi Y, et al. Dysmenorrhea in Japanese women. Int J Gynaecol Obstet. 2005;88:82–83. doi: 10.1016/j.ijgo.2004.09.004.
    1. Japan Society of Obstetrics and Gynecology, and Japan Association of Obstetricians and Gynecologists. [Guideline for gynecological practice in Japan, 2017]. . Accessed Nov 17, 2021. (In Japanese).
    1. Ministry of Health, Labour and Welfare. [Health Sciences Research: Children’s Household Comprehensive Research Project; a questionnaire survey of 10,000 general women]. . Accessed Sep 4, 2021. (In Japanese).
    1. Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci. 2010;115:138–145. doi: 10.3109/03009730903457218.
    1. Wong CL. Health-related quality of life among Chinese adolescent girls with dysmenorrhoea. Reprod Health. 2018;15:80. doi: 10.1186/s12978-018-0540-5.
    1. Tabuchi Y, Yoshidome A, Ban N, Kumagai Y, Kusama T. A survey of the relationship between HRQoL and menstrual symptoms in Japanese patients with endometriosis. Health Care. 2016;58:567–572.
    1. Eryilmaz G, Ozdemir F, Pasinlioglu T. Dysmenorrhea prevalence among adolescents in eastern Turkey: its effects on school performance and relationships with family and friends. J Pediatr Adolesc Gynecol. 2010;23:267–272. doi: 10.1016/j.jpag.2010.02.009.
    1. Wong LP, Khoo EM. Dysmenorrhea in a multiethnic population of adolescent Asian girls. Int J Gynaecol Obstet. 2010;108:139–142. doi: 10.1016/j.ijgo.2009.09.018.
    1. Ortiz MI, Rangel-Flores E, Carrillo-Alarcon LC, Veras-Godoy HA. Prevalence and impact of primary dysmenorrhea among Mexican high school students. Int J Gynaecol Obstet. 2009;107:240–243. doi: 10.1016/j.ijgo.2009.07.031.
    1. Kawaguchi R, Matsumoto K, Akira S, et al. Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition. J Obstet Gynaecol Res. 2019;45:766–786. doi: 10.1111/jog.13831.
    1. Momoeda M, Akiyama S, Tanaka K, Suzukamo Y. Quality of life in Japanese patients with dysmenorrhea treated with ethinylestradiol 20 μg/drospirenone 3 mg in a real-world setting: an observational study. Int J Womens Health. 2020;12:327–338. doi: 10.2147/IJWH.S238460.
    1. Kumano S. GPSP: good post-marketing study practice. Nihon Yakurigaku Zasshi. 2012;140(2):81–84. doi: 10.1254/fpj.140.81.
    1. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968;30:853–867. doi: 10.1097/00006842-196811000-00006.
    1. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365. doi: 10.2165/00019053-199304050-00006.
    1. Yamamoto S, Ishimori S, Sunaya T, Watanabe A, Sato S. The evaluation of safety and efficacy of drospirenone- and ethinylestradiol-containing tablet in patients with pain associated with endometriosis and patients with dysmenorrhea—report of interim analysis of use-result survey. Therapeutic Res. 2020;41:381–396.
    1. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;4:582–592.
    1. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:171–184. doi: 10.1586/erp.11.9.
    1. Tsuno Y. Health and productivity of medical professionals in medical institutions: from the viewpoint of health management. Soc Secur Res. 2019;3:492–504.
    1. The Japan Society of Obstetrics and Gynecology/The Japan Society for Menopause and Women’s Health. [Guidelines concerning the use of OC/low-dose estrogen–progestin 2020]. 2021. . Accessed Sep 4, 2021. (In Japanese).
    1. Momoeda M, Akiyama S, Yamamoto S, Kondo M, Fukai T. Burden of menstrual pain measured by heatmap visualization of daily patient-reported data in Japanese patients treated with ethinylestradiol/drospirenone: a randomized controlled study. Int J Womens Health. 2020;12:175–185. doi: 10.2147/IJWH.S242864.

Source: PubMed

3
Subskrybuj